|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C60.9 |
Malignant neoplasm of penis, unspecified
Diagnosis Valid for Male Patient Only
|
C609 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 57.07%
|
21.13%
|
9.78%
|
3.96%
|
2.26%
|
1.60%
|
1.14%
|
1.19%
|
0.51%
|
0.37%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C60.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,248
|
1,253
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
635
|
638
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
590
|
590
|
|
80053
|
COMPREHEN METABOLIC PANEL |
588
|
588
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
488
|
48,895
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
372
|
372
|
|
71260
|
CT THORAX DX C+ |
262
|
262
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
258
|
1,102
|
|
J3010
|
FENTANYL CITRATE INJECTION |
255
|
443
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
254
|
383
|
|
82565
|
ASSAY OF CREATININE |
229
|
229
|
|
80048
|
METABOLIC PANEL TOTAL CA |
228
|
228
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
219
|
6,048
|
|
J2405
|
ONDANSETRON HCL INJECTION |
211
|
1,004
|
|
G1004
|
CDSM NDSC |
183
|
235
|
|
85027
|
COMPLETE CBC AUTOMATED |
174
|
174
|
|
83735
|
ASSAY OF MAGNESIUM |
157
|
157
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
146
|
594
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
143
|
1,071
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
128
|
2,790
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C60.9 related to the following DRG Codes:
715-716
722-724
|
